Abstract
Necrotizing enterocolitis (NEC) is a devastating gastrointestinal emergency in preterm infants and the clinical presentation of NEC may vary with gestational age. We lack reliable biomarkers for early diagnosis of NEC limiting timely intervention. Hematological changes in NEC are actively researched for their potential role as biomarkers. The pattern and severity of hematological abnormalities have been correlated with rapid progression, the need for surgery, increased risk of mortality, and morbidity. In this issue of Pediatric Research, Chong et al. report GA-specific hematological biomarkers in preterm infants with NEC that could predict the need for surgery. Thrombocytopenia at NEC onset was an independent predictor of surgical intervention in extremely preterm infants. Persistent thrombocytopenia and lymphopenia at 72 h and elevated C-reactive protein at 48 h after NEC onset, predicted surgery in infants of 28 to <32 weeks GA. Persistent thrombocytopenia at 24 h after the onset of NEC was predictive of mortality in infants who underwent surgery. Well-designed, prospective, multi-center studies are needed to confirm the role of hematological biomarkers in early diagnosis and prognostication in NEC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 14 print issues and online access
$259.00 per year
only $18.50 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Alsaied, A., Islam, N. & Thalib, L. Global incidence of necrotizing enterocolitis: a systematic review and meta-analysis. BMC Pediatr. 20, 344 (2020).
Bell, E. F. et al. Mortality, in-hospital morbidity, care practices, and 2-year outcomes for extremely preterm infants in the US, 2013–2018. JAMA 327, 248–263 (2022).
Zozaya, C. et al. Incidence, treatment, and outcome trends of necrotizing enterocolitis in preterm infants: a multicenter cohort study. Front Pediatr. 8, 188 (2020).
Lu, Q., Cheng, S., Zhou, M. & Yu, J. Risk factors for necrotizing enterocolitis in neonates: a retrospective case-control study. Pediatr. Neonatol. 58, 165–170 (2017).
Sampath, V. et al. Sigirr genetic variants in premature infants with necrotizing enterocolitis. Pediatrics 135, e1530–e1534 (2015).
Youn, Y. A., Kim, E. K. & Kim, S. Y. Necrotizing enterocolitis among very-low-birth-weight infants in Korea. J. Korean Med. Sci. 30, S75–80 (2015).
Samuels, N., van de Graaf, R. A., de Jonge, R. C. J., Reiss, I. K. M. & Vermeulen, M. J. Risk factors for necrotizing enterocolitis in neonates: a systematic review of prognostic studies. BMC Pediatr. 17, 105 (2017).
Zvizdic, Z. et al. Contributing factors for development of necrotizing enterocolitis in preterm infants in the neonatal intensive care unit. Mater. Sociomed. 28, 53–56 (2016).
Hackam, D. J. & Sodhi, C. P. Bench to bedside - new insights into the pathogenesis of necrotizing enterocolitis. Nat. Rev. Gastroenterol. Hepatol. 19, 468–479 (2022).
Jones, I. H. & Hall, N. J. Contemporary outcomes for infants with necrotizing enterocolitis-a systematic review. J. Pediatr. 220, 86–92.e83 (2020).
Mowitz, M. E., Dukhovny, D. & Zupancic, J. A. F. The cost of necrotizing enterocolitis in premature infants. Semin Fetal Neonatal Med. 23, 416–419 (2018).
Sparks, E. A. et al. Necrotizing enterocolitis is associated with earlier achievement of enteral autonomy in children with short bowel syndrome. J. Pediatr. Surg. 51, 92–95 (2016).
Fredriksson, F. & Engstrand Lilja, H. Survival rates for surgically treated necrotising enterocolitis have improved over the last four decades. Acta Paediatr. 108, 1603–1608 (2019).
Maheshwari, A. Immunologic and hematological abnormalities in necrotizing enterocolitis. Clin. Perinatol. 42, 567–585 (2015).
Mandel, D. et al. Nucleated red blood cells in preterm infants who have necrotizing enterocolitis. J. Pediatr. 144, 653–655 (2004).
Baschat, A. A. et al. Nucleated red blood cell counts in the first week of life: a critical appraisal of relationships with perinatal outcome in preterm growth-restricted neonates. Am. J. Obstet. Gynecol. 197, 286.e281–288 (2007).
Kim, D. H., Bae, S. P., Hahn, W.-H., Song, J.H. & Oh, M. H. Low basophil count and red cell distribution width at birth may predict the development of neonatal necrotizing enterocolitis: a matched control study. Soonchunhyang Med. Sci. 19, 61–64 (2013).
Mu, Y. & Wang, H. Association of neutrophil to lymphocyte ratio with preterm necrotizing enterocolitis: a retrospective case-control study. BMC Gastroenterol. 22, 248 (2022).
Song, R., Subbarao, G. C. & Maheshwari, A. Haematological abnormalities in neonatal necrotizing enterocolitis. J. Matern. Fetal Neonatal Med. 25, 22–25 (2012).
Desiraju, S., Bensadoun, J., Bateman, D. & Kashyap, S. The role of absolute monocyte counts in predicting severity of necrotizing enterocolitis. J. Perinatol. 40, 922–927 (2020).
Wang, Z. et al. Reduction of absolute monocyte counts is associated with the severity of preterm necrotizing enterocolitis. J. Pediatr. 99, 449–455 (2023).
Remon, J. et al. Acute drop in blood monocyte count differentiates NEC from other causes of feeding intolerance. J. Perinatol. 34, 549–554 (2014).
Qin, F. et al. Association of neutropenia at disease onset with severe surgical necrotizing enterocolitis and higher mortality: a retrospective study. Front. Surg. 9, 971898 (2022).
Garg, P. M. et al. Hematological predictors of mortality in neonates with fulminant necrotizing enterocolitis. J. Perinatol. 41, 1110–1121 (2021).
Lambert, D. K. et al. Fulminant necrotizing enterocolitis in a multihospital healthcare system. J. Perinatol. 32, 194–198 (2012).
Garg, P. M. et al. Gestational age-specific hematological patterns in preterm infants following necrotizing enterocolitis. J. Matern. Fetal Neonatal Med. 35, 10093–10102 (2022).
Pantalone, J. M. et al. Gestational age-specific complete blood count signatures in necrotizing enterocolitis. Front. Pediatr. 9, 604899 (2021).
Kenton, A. B. et al. Severe thrombocytopenia predicts outcome in neonates with necrotizing enterocolitis. J. Perinatol. 25, 14–20 (2005).
Ververidis, M. et al. The clinical significance of thrombocytopenia in neonates with necrotizing enterocolitis. J. Pediatr. Surg. 36, 799–803 (2001).
Davenport, P. & Sola-Visner, M. Hemostatic challenges in neonates. Front. Pediatr. 9, 627715 (2021).
Sokou, R. et al. Assessment of hemostatic profile in neonates with necrotizing enterocolitis using rotational thromboelastometry (Rotem). Pediatr. Res. https://doi.org/10.1038/s41390-023-02958-8 (2023).
Roseff, S. D. Cryptantigens: time to uncover the real significance of T-activation. Transfusion 57, 2553–2557 (2017).
Crookston, K. P. et al. RBC T activation and hemolysis: implications for pediatric transfusion management. Transfusion 40, 801–812 (2000).
Battersby, C., Longford, N., Costeloe, K. & Modi, N. Development of a gestational age-specific case definition for neonatal necrotizing enterocolitis. JAMA Pediatr. 171, 256–263 (2017).
Funding
Dr. Mohan Pammi is funded by the following extramural source: NIH 1R01HD112886.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mani, S., Garg, P.M. & Pammi, M. Do hematological biomarkers predict surgical necrotizing enterocolitis?. Pediatr Res (2024). https://doi.org/10.1038/s41390-024-03066-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41390-024-03066-x